Tela Bio Stock EBITDA
| TELA Stock | USD 4.72 0.09 1.94% |
Tela Bio fundamentals help investors to digest information that contributes to Tela Bio's financial success or failures. It also enables traders to predict the movement of Tela Stock. The fundamental analysis module provides a way to measure Tela Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tela Bio stock.
| Last Reported | Projected for Next Year | ||
| EBITDA | -43.3 M | -45.4 M |
Tela | EBITDA |
Tela Bio Company EBITDA Analysis
Tela Bio's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Tela Bio EBITDA | (43.27 M) |
Most of Tela Bio's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tela Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Tela EBITDA Driver Correlations
Understanding the fundamental principles of building solid financial models for Tela Bio is extremely important. It helps to project a fair market value of Tela Stock properly, considering its historical fundamentals such as EBITDA. Since Tela Bio's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Tela Bio's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Tela Bio's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
Tela Ebitda
Ebitda |
|
According to the company disclosure, Tela Bio reported earnings before interest,tax, depreciation and amortization of (43.27 Million). This is 104.93% lower than that of the Health Care Equipment & Supplies sector and 106.73% lower than that of the Health Care industry. The ebitda for all United States stocks is 101.11% higher than that of the company.
Tela EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tela Bio's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Tela Bio could also be used in its relative valuation, which is a method of valuing Tela Bio by comparing valuation metrics of similar companies.Tela Bio is currently under evaluation in ebitda category among related companies.
Tela Bio Current Valuation Drivers
We derive many important indicators used in calculating different scores of Tela Bio from analyzing Tela Bio's financial statements. These drivers represent accounts that assess Tela Bio's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Tela Bio's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 147.7M | 194.5M | 185.3M | 151.4M | 136.3M | 113.6M | |
| Enterprise Value | 132.7M | 151.0M | 172.8M | 147.4M | 132.7M | 104.4M |
Tela Bio Institutional Holders
Institutional Holdings refers to the ownership stake in Tela Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Tela Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Tela Bio's value.| Shares | Paradigm Capital Management, Inc. | 2023-12-31 | 498.5 K | Kennedy Capital Management Inc | 2023-12-31 | 382.2 K | Geode Capital Management, Llc | 2023-12-31 | 346.7 K | Worth Venture Partners, Llc | 2023-12-31 | 345.3 K | State Street Corporation | 2023-12-31 | 320.5 K | Stonepine Capital Management Llc | 2023-12-31 | 317.8 K | Perkins Capital Management Inc | 2023-12-31 | 210.2 K | Jacob Asset Mgmt Of Ny Llc | 2023-09-30 | 159.8 K | Northern Trust Corp | 2023-12-31 | 135.1 K | Essex Woodlands Health Ventures | 2023-12-31 | 4.1 M | Orbimed Advisors, Llc | 2023-12-31 | 2.8 M |
Tela Fundamentals
| Return On Equity | -2.81 | ||||
| Return On Asset | -0.38 | ||||
| Profit Margin | (0.80) % | ||||
| Operating Margin | (0.72) % | ||||
| Current Valuation | 112.38 M | ||||
| Shares Outstanding | 24.65 M | ||||
| Shares Owned By Insiders | 2.27 % | ||||
| Shares Owned By Institutions | 87.71 % | ||||
| Number Of Shares Shorted | 925.98 K | ||||
| Price To Book | 6.42 X | ||||
| Price To Sales | 2.07 X | ||||
| Revenue | 58.45 M | ||||
| Gross Profit | 27.85 M | ||||
| EBITDA | (43.27 M) | ||||
| Net Income | (46.66 M) | ||||
| Cash And Equivalents | 27.73 M | ||||
| Cash Per Share | 1.90 X | ||||
| Total Debt | 42.78 M | ||||
| Debt To Equity | 3.33 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 0.77 X | ||||
| Cash Flow From Operations | (40.86 M) | ||||
| Short Ratio | 5.77 X | ||||
| Earnings Per Share | (2.04) X | ||||
| Target Price | 14.6 | ||||
| Number Of Employees | 227 | ||||
| Beta | 0.95 | ||||
| Market Capitalization | 116.37 M | ||||
| Total Asset | 78.05 M | ||||
| Retained Earnings | (320.89 M) | ||||
| Working Capital | 54.76 M | ||||
| Net Asset | 78.05 M |
About Tela Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tela Bio's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tela Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tela Bio based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Tela Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Tela Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tela Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tela Bio Stock:Check out Tela Bio Piotroski F Score and Tela Bio Altman Z Score analysis. For information on how to trade Tela Stock refer to our How to Trade Tela Stock guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Complementary Tools for Tela Stock analysis
When running Tela Bio's price analysis, check to measure Tela Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tela Bio is operating at the current time. Most of Tela Bio's value examination focuses on studying past and present price action to predict the probability of Tela Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tela Bio's price. Additionally, you may evaluate how the addition of Tela Bio to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Directory Find actively traded commodities issued by global exchanges |
Is Tela Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Tela Bio. If investors know Tela will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Tela Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.04) | Revenue Per Share 2.556 | Quarterly Revenue Growth 0.463 | Return On Assets (0.38) | Return On Equity (2.81) |
The market value of Tela Bio is measured differently than its book value, which is the value of Tela that is recorded on the company's balance sheet. Investors also form their own opinion of Tela Bio's value that differs from its market value or its book value, called intrinsic value, which is Tela Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Tela Bio's market value can be influenced by many factors that don't directly affect Tela Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Tela Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Tela Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Tela Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.